Synnovis

Congratulations to Synnovis' Non-Executive Director Sneh Khemka on being awarded CBE (Commander of the Order of the British Empire) for his outstanding contribution to healthcare, science, innovation and technology. The expertise he brings to our board is invaluable and this recognition is truly well deserved.

The new year is nearly here, so we’re taking a moment to celebrate our best loved posts of the past 12 months. You can check them out in full at the links below. 1️⃣ On 2 April we celebrated a very important milestone – our state-of-the-art hub received and processed its very first #pathology samples! More than five years of planning has been invested in our hub, so this moment was an exciting one to mark. https://ow.ly/6xCK50UygRV 2️⃣ A month later we were able to showcase our progress inside the hub, showing off the cutting-edge technology helping our teams support the treatment of patients in south east London. https://ow.ly/Qrbu50UygRU 3️⃣ We celebrated the first drone deliveries of urgent patient samples between our labs at Guy's and St Thomas' NHS Foundation Trust in November. We’ve been thrilled to be part of the trial run by Apian and the Trust and look forward to being part of its success in 2025. https://ow.ly/Ar4B50UygRX 4️⃣ Eight months on from our first samples arriving in Blackfriars we showcased how things have progressed in our hub while our first teams have been in residence. https://ow.ly/wBMy50UygRW 5️⃣ It wasn’t just the hub we were celebrating this year. Synnovis Principal Clinical Scientist Rue Ball was recognised at a global level for a trial she ran at King's College Hospital NHS Foundation Trust which is helping to close the knowledge gap in trans healthcare. https://ow.ly/C14v50UygRT As 2024 draws to a close we’re wishing everyone a happy and healthy new year and looking forward to a great 2025!

Well deserved congratulations to Professor Safa Al-Sarraj on his OBE (Order of the British Empire) for services to neuropathology. His contribution to Synnovis' Ultra Specialist Services neuropathology unit at King's College Hospital NHS Foundation Trust has been profound. #OBE #NewYearsHonours

Our CEO Mark Dollar was recently joined by Rainar Aamisepp, David Bennett, David James and Dominic Harrington in visiting the drones carrying patient samples between our labs at Guy's and St Thomas' NHS Foundation Trust. These drones are part of a trial run by Apian and the Trust which we’re very glad to be supporting. They allow samples to be transported between sites in under two minutes, allowing specialist testing to be completed sooner and patients to receive urgent treatment more quickly. It’s been fantastic to be part of the success of this trial, and we’re looking forward to continuing to work with Apian into the future.

We had a great time showing Howard Dawber, Deputy Mayor of London for Business and Growth, the exciting medical drone delivery service run by Apian between our labs at Guy's and St Thomas' NHS Foundation Trust. It was great opportunity to showcase how transporting urgent samples more quickly can allow for faster turnaround of testing and results for patients who need it most.

As a leading international diagnostics provider, we serve many patients, healthcare professionals and communities and employ over 27,000 employees on 4 continents. Our commitment to high-quality healthcare is a key pathway to protecting and promoting human rights. We interviewed Catharina Monster, MBA, who is both our Group Chief Human Resources Officer and Chief Human Rights Officer. Watch the video to learn more about how understanding and respecting human rights are an integral part of our activities worldwide.  #HumanRightsDay #ESG #diagnostics

It’s been 8 months since the first patient samples arrived at our state-of-the-art hub laboratory in south east London, and our progress is gathering pace. When our transformation programme is complete our hub will serve almost 2 million patients in the area and process more than a 1,000,000 tests per day. It will also free up space across Trust sites for other important NHS services. It’s a fantastic place to be, with 10 floors of cutting-edge lab space and dedicated and inspiring colleagues working across the floors we’ve moved into so far. It’s great to be able to celebrate our progress as our transformation of pathology services for patients in south east London continues. Check out the latest on our hub ⬇️ #PathologyHub #CareersinScience #HubLaboratory

We were thrilled last week to join Apian in welcoming the Minister for Aviation, Mike Kane MP, and officials from Department for Transport (DfT), United Kingdom to Guy's and St Thomas' NHS Foundation Trust. The Minister’s visit was an excellent opportunity to showcase the way Apian has partnered with the Trust to deliver blood samples for urgent testing between our Synnovis labs at both hospitals. Our team had the opportunity to demonstrate the process of preparing a sample for delivery, and the Minister was able to play a role in readying it for collection by drone. Reflecting on the visit, Professor Dominic Harrington, Chief Scientific Officer, Synnovis said: "We’re proud to be working with Apian and Guy’s and St Thomas’ NHS Foundation Trust on this pioneering project, already making a real difference to the lives of patients. Transporting samples between sites so quickly means our pathology laboratory teams can analyse them sooner and inform the best possible care for those needing urgent treatment. Our team was delighted to show the Minister the work we’re doing, and the impact this project will have on patients in south east London”.

Last week marked the first deliveries of urgent blood samples by Apian drones between our labs at Guy's and St Thomas' NHS Foundation Trust. These drones can make the journey between sites in under 2 minutes, representing a dramatic decrease from the nearly half hour road journey and a significant positive impact for patients awaiting urgent treatment or surgery. Professor Dominic Harrington, Chief Scientific Officer, Synnovis, said: "Tens of thousands of essential patient samples are analysed by pathology laboratories across London each week. Reducing the time it takes to transport these samples means results are available more quickly to inform best possible patient care. We’re excited to be working with Apian on this pioneering project and look forward to seeing where this can go next.” This innovative solution will have a positive impact on both patient care and the environment, and we’re very proud to be supporting it. https://lnkd.in/deQffUCv

At Synnovis we're helping to improve care for breast cancer patients by introducing a liquid biopsy technique, called circulating tumour DNA (ctDNA) testing, to monitor and detect tumour progression. Healthcare professionals can provide patients with accurate data and treatment based on information collected from a simple blood sample, potentially eliminating the need for invasive biopsies. Liquid biopsy technology has the potential to: ➡ reduce or avoid invasive biopsies ➡ identify other tumours in the body, which could otherwise be missed ➡ achieve quicker results for patients ➡ reduce the need for follow-up investigations. Learn more from Synnovis geneticists Persephone du Parcq, Gareth Gerrard and Deborah Ruddy about how scientific excellence and patient centricity are at the heart of this cutting-edge service. SYNLAB UK & Ireland #BreastCancerAwareness #PinkOctober #liquidbiopsy #oncology